Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Susan H. Eshleman(Johns Hopkins University), David Burns(Norwegian Womens Public Health Association), Breno Santos(Hospital Nossa Senhora da Conceição), Vanessa Elharrar(National Institutes of Health), Myron S. Cohen(University of North Carolina at Chapel Hill), Joseph J. Eron(University of North Carolina at Chapel Hill), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Kenneth H. Mayer(Miriam Hospital), Lisa Mills(Kenya Medical Research Institute), Suwat Chariyalertsak(Chiang Mai University), Estelle Piwowar‐Manning(Johns Hopkins University), Johnstone Kumwenda(Blantyre Institute for Community Ophthalmology), Guy de Bruyn(University of Namur), James Hakim(University of Zimbabwe), Karin Nielsen‐Saines(University of California, Los Angeles), Susan Swindells(University of Nebraska Medical Center), Marybeth McCauley(Family Health International 360), Joel E. Gallant(Johns Hopkins University), Ian Sanne(University of the Witwatersrand), Joseph Makhema(Norwegian Womens Public Health Association), Sanjay Mehendale(P. D. Hinduja Hospital and Medical Research Centre), Taha E. Taha(Blantyre Institute for Community Ophthalmology), Theresa Gamble(University of Utah), Diane V. Havlir(University of California, San Francisco), José Henrique Pilotto(Universidade Iguaçu), Ying Qing Chen(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Sheela Godbole(The Ohio State University Wexner Medical Center), Irving Hoffman(Communities In Schools of Orange County), Nagalingeswaran Kumarasamy(University of North Carolina at Chapel Hill), Heather J. Ribaudo(Cancer Research And Biostatistics), Lei Wang(Shanghai Jiao Tong University), Mina C. Hosseinipour
Cited by 0
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k